New York Valves™ 2025 late-breaking clinical trials announced
Meeting Announcement
Updates every hour. Last Updated: 16-Nov-2025 01:11 ET (16-Nov-2025 06:11 GMT/UTC)
CRF announced the lineup of Late-Breaking Clinical Trials to be presented at New York Valves: The Structural Heart Summit taking place June 25-27, 2025, at the Jacob K. Javits Convention Center, North in New York, NY.
What if people could detect cancer and other diseases with the same speed and ease of a pregnancy test or blood glucose meter? Researchers at the Carl R. Woese Institute for Genomic Biology are a step closer to realizing this goal by integrating machine learning-based analysis into point-of-care biosensing technologies.
The new method, dubbed LOCA-PRAM, was reported in the journal Biosensors and Bioelectronics and improves the accessibility of biomarker detection by eliminating the need for technical experts to perform the image analysis.
A new grant from the National Institutes of Health (NIH) will help Wayne State University researchers explore potential connections between per- and polyfluoroalkyl substances (PFAS) exposure and adverse effects on male reproductive health.
Researchers at Karolinska Institutet and Lund University in Sweden have identified a new treatment strategy for neuroblastoma, an aggressive form of childhood cancer. By combining two antioxidant enzyme inhibitors, they have converted cancer cells in mice into healthy nerve cells. The study is published in the journal Proceedings of the National Academy of Sciences (PNAS).
Research builds on Emory’s research on influenza vaccines self-administered via Micron’s microarray technology. This trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology.